mTerra Ventures
53 State Street 15th Floor, Boston, MA, 02109, United States
Overview
mTerra Ventures is a company to track, compare, and analyse startups for venture capitals.
- Total investments
- 3
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- Captura
Participated · Series B · Jun 2026
Captura designs and manufactures a PFAS-free bipolar membrane electrodialysis platform that generates acid and base streams for applications including direct lithium extraction, industrial water treatment, long-duration energy storage, and CO2 management. The platform was originally developed to power Captura’s Direct Ocean Capture (DOC) system, which removes CO2 from seawater for permanent storage or utilization. Captura operates the only U.S.-based production plant that produces complete electrodialysis systems and plans to scale domestic manufacturing capacity following its Series B raise. The company reports that its technology offers greater performance with significantly lower energy consumption and capital costs compared with leading market alternatives. Captura recently secured multiple purchase orders for its first electrodialysis stacks addressing the lithium extraction market, with initial deliveries expected this summer. CEO Steve Oldham says the company is now manufacturing systems for customers while continuing to advance commercial deployment of DOC globally.
- Spensa Technologies
Participated · Series A · Nov 2015
Spensa Technologies develops insect detection hardware and software for precision pest management. Its core hardware product, the Z‑Trap insect sensor, has been on the market for three years but remains at a small‑scale manufacturing level. The company is also building OpenScout, a software platform that aggregates manual observations of insects, disease and weeds to predict pest emergence, economic impact, and optimize spray programs. Proceeds from the recent raise will be used to grow the team (currently 35 employees) and scale Z‑Trap manufacturing through 2017. Spensa has formed strategic partnerships with AgReliant Genetics, Bayer, Syngenta and large agricultural retailers and cooperatives to commercialize its products. The company expected roughly $2 million in revenue in 2015, above initial estimates.
Team
No current team members are available.